Framingham drugmaker to be acquired for $1.9B
KalVista Pharmaceuticals in Framingham is set to be acquired by Italy-based Chiesi Group in a $1.9-billion deal, positioning the rare disease drug developer to scale its drug therapy on a global stage.
📰 Original Source
Read full article at Wbjournal →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.